Trial Profile
Comparison of the effects of midazolam and omeprazole on patupilone pharmacokinetics, efficacy, and safety in patients with advanced cancers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2012
Price :
$35
*
At a glance
- Drugs Patupilone (Primary) ; Midazolam; Omeprazole
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Novartis
- 04 Jan 2012 New trial record
- 01 Dec 2011 Results published in the Cancer Chemotherapy and Pharmacology.